[1]
|
Bundy, L.M., Rajnik, M. and Noor, A. (2013) Neonatal Meningitis. StatPearls, Treasure Island.
|
[2]
|
Baud, O. and Aujard, Y. (2013) Neonatal Bacterial Meningitis. Handbook of Clinical Neurology, 112, 1109-1113. https://doi.org/10.1016/B978-0-444-52910-7.00030-1
|
[3]
|
Ouchenir, L., Renaud, C., Khan, S., et al. (2017) The Epidemiology, Management, and Outcomes of Bacterial Meningitis in Infants. Pediatrics, 140, e20170476. https://doi.org/10.1542/peds.2017-0476
|
[4]
|
廖镇宇, 常淑婷, 肖勇, 等. 早产儿细菌性脑膜炎临床分析[J]. 中国感染控制杂志, 2022, 21(10): 1006-1014.
|
[5]
|
Zhai, Q., Li, S., Zhang, L., et al. (2022) Changes in Pathogens of Neonatal Bacterial Meningitis over the Past 12 Years: A Single-Center Retrospective Study. Translational Pediatrics, 11, 1595-1603. https://doi.org/10.21037/tp-22-103
|
[6]
|
Ueno, M., Chiba, Y., Murakami, R., et al. (2016) Blood-Brain Barrier and Blood-Cerebrospinal Fluid Barrier in Normal and Pathological Conditions. Brain Tumor Pathology, 33, 89-96. https://doi.org/10.1007/s10014-016-0255-7
|
[7]
|
Gawdi, R., Shumway, K.R. and Emmady, P.D. (2023) Physiology, Blood Brain Barrier. StatPearls, Treasure Island.
|
[8]
|
Kim, B.J., Hancock, B.M., Bermudez, A., et al. (2015) Bacterial Induction of Snail1 Contributes to Blood-Brain Barrier Disruption. Journal of Clinical Investigation, 125, 2473-83. https://doi.org/10.1172/JCI74159
|
[9]
|
Deshayes De Cambronne, R., Fouet, A., Picart, A., et al. (2021) CC17 Group B Streptococcus Exploits Integrins for Neonatal Meningitis Development. Journal of Clinical Investigation, 131, e136737. https://doi.org/10.1172/JCI136737
|
[10]
|
Zhu, N., Liu, W., Prakash, A., et al. (2020) Targeting E. coli Invasion of the Blood-Brain Barrier for Investigating the Pathogenesis and Therapeutic Development of E. coli Meningitis. Cellular Microbiology, 22, e13231. https://doi.org/10.1111/cmi.13231
|
[11]
|
Doran, K.S., Fulde, M., Gratz, N., et al. (2016) Host-Pathogen Interactions in Bacterial Meningitis. Acta Neuropathologica, 131, 185-209. https://doi.org/10.1007/s00401-015-1531-z
|
[12]
|
Gong, Z., Gao, X., Li, Y., et al. (2022) α7 Nicotinic Acetylcholine Receptor Antagonists Prevent Meningitic Escherichia coli-Induced Blood-Brain Barrier Disruptions by Targeting the CISH/JAK2/STAT5b Axis. Biomedicines, 10, Article 2358. https://doi.org/10.3390/biomedicines10102358
|
[13]
|
He, X., Wang, L., Liu, L., et al. (2021) Endogenous α7 NAChR Agonist SLURP1 Facilitates Escherichia coli K1 Crossing the Blood-Brain Barrier. Frontiers in Immunology, 12, Article 745854. https://doi.org/10.3389/fimmu.2021.745854
|
[14]
|
Liu, R., Wu, C., Li, L., et al. (2019) CD48 and α7 Nicotinic Acetylcholine Receptor Synergistically Regulate FimH-Mediated Escherichia coli K1 Penetration and Neutrophil Transmigration across Human Brain Microvascular Endothelial Cells. The Journal of Infectious Diseases, 219, 470-479. https://doi.org/10.1093/infdis/jiy531
|
[15]
|
Fan, Y., Sun, H., Yang, W., et al. (2022) YbdO Promotes the Pathogenicity of Escherichia coli K1 by Regulating Capsule Synthesis. International Journal of Molecular Sciences, 23, Article 5543. https://doi.org/10.3390/ijms23105543
|
[16]
|
Fan, Y., Bai, J., Xi, D. and Yang, B. (2022) RpoE Facilitates Stress-Resistance, Invasion, and Pathogenicity of Escherichia coli K1. Microorganisms, 10, Article 879. https://doi.org/10.3390/microorganisms10050879
|
[17]
|
Loh, L.N., McCarthy, E.M.C., Narang, P., et al. (2017) Escherichia coli K1 Utilizes Host Macropinocytic Pathways for Invasion of Brain Microvascular Endothelial Cells. Traffic, 18, 733-746. https://doi.org/10.1111/tra.12508
|
[18]
|
Chambers, C.A., Dadelahi, A.S., Moley, C.R., et al. (2022) Nucleotide Receptors Mediate Protection against Neonatal Sepsis and Meningitis Caused by α-Hemolysin Expressing Escherichia coli K1. The FASEB Journal, 36, e22197. https://doi.org/10.1096/fj.202101485R
|
[19]
|
Huang, S.H., Chi, F., Peng, L., et al. (2016) Vimentin, a Novel NF-κB Regulator, Is Required for Meningitic Escherichia coli K1-Induced Pathogen Invasion and PMN Transmigration across the Blood-Brain Barrier. PLOS ONE, 11, e0162641. https://doi.org/10.1371/journal.pone.0162641
|
[20]
|
Krishnan, S., Chang, A.C., Stoltz, B.M. and Prasadarao, N.V. (2016) Escherichia coli K1 Modulates Peroxisome Proliferator-Activated Receptor γ and Glucose Transporter 1 at the Blood-Brain Barrier in Neonatal Meningitis. The Journal of Infectious Diseases, 214, 1092-1104. https://doi.org/10.1093/infdis/jiw306
|
[21]
|
Wu, C., Yang, M., Liu, R., et al. (2020) Nicotine Reduces Human Brain Microvascular Endothelial Cell Response to Escherichia coli K1 Infection by Inhibiting Autophagy. Frontiers in Cellular and Infection Microbiology, 10, Article 484. https://doi.org/10.3389/fcimb.2020.00484
|
[22]
|
Liu, P., Wang, X., Yang, Q., et al. (2022) Collaborative Action of Microglia and Astrocytes Mediates Neutrophil Recruitment to the CNS to Defend Against Escherichia coli K1 Infection. International Journal of Molecular Sciences, 23, Article 6540. https://doi.org/10.3390/ijms23126540
|
[23]
|
Jha, M.K., Jo, M., Kim, J.H., et al. (2019) Microglia-Astrocyte Crosstalk: An Intimate Molecular Conversation. Neuroscientist, 25, 227-240. https://doi.org/10.1177/1073858418783959
|
[24]
|
Michael, B.D., Bricio-Moreno, L., Sorensen, E.W., et al. (2020) Astrocyte-and Neuron-Derived CXCL1 Drives Neutrophil Transmigration and Blood-Brain Barrier Permeability in Viral Encephalitis. Cell Reports, 32, Article ID: 108150. https://doi.org/10.1016/j.celrep.2020.108150
|
[25]
|
Thorsdottir, S., Henriques-Normark, B. and Iovino, F. (2019) The Role of Microglia in Bacterial Meningitis: Inflammatory Response, Experimental Models and New Neuroprotective Therapeutic Strategies. Frontiers in Microbiology, 10, Article 576. https://doi.org/10.3389/fmicb.2019.00576
|
[26]
|
Diesselberg, C., Ribes, S., Seele, J., Kaufmann, A., et al. (2018) Activin a Increases Phagocytosis of Escherichia coli K1 by Primary Murine Microglial Cells Activated by Toll-Like Receptor Agonists. Journal of Neuroinflammation, 15, Article No. 175. https://doi.org/10.1186/s12974-018-1209-2
|
[27]
|
Liddelow, S.A., Guttenplan, K.A., Clarke, L.E., et al. (2017) Neurotoxic Reactive Astrocytes Are Induced by Activated Microglia. Nature, 541, 481-487. https://doi.org/10.1038/nature21029
|
[28]
|
Jo, M., Kim, J.H., Song, G.J., et al. (2017) Astrocytic Orosomucoid-2 Modulates Microglial Activation and Neuroinflammation. Journal of Neuroscience, 37, 2878-2894. https://doi.org/10.1523/JNEUROSCI.2534-16.2017
|
[29]
|
Molino, Y., Jabès, F., Lacassagne, E., et al. (2014) Setting-Up an in Vitro Model of Rat Blood-Brain Barrier (BBB): A Focus on BBB Impermeability and Receptor-Mediated Transport. Journal of Visualized Experiments, 88, e51278. https://doi.org/10.3791/51278
|
[30]
|
Bohannon, D.G., Long, D. and Kim, W.K. (2021) Understanding the Heterogeneity of Human Pericyte Subsets in Blood-Brain Barrier Homeostasis and Neurological Diseases. Cells, 10, Article 890. https://doi.org/10.3390/cells10040890
|
[31]
|
Heymans, M., Figueiredo, R., Dehouck, L., et al. (2020) Contribution of Brain Pericytes in Blood-Brain Barrier Formation and Maintenance: A Transcriptomic Study of Cocultured Human Endothelial Cells Derived from Hematopoietic Stem Cells. Fluids and Barriers of the CNS, 17, Article No. 48. https://doi.org/10.1186/s12987-020-00208-1
|
[32]
|
Kim, J., Lee, K.T., Lee, J.S., et al. (2021) Fungal Brain Infection Modelled in a Human-Neurovascular-Unit-on-a-Chip with a Functional Blood-Brain Barrier. Nature Biomedical Engineering, 5, 830-846. https://doi.org/10.1038/s41551-021-00743-8
|
[33]
|
Abbott, N.J., Dolman, D.E., Drndarski, S., et al. (2012) An Improved in Vitro Blood-Brain Barrier Model: Rat Brain Endothelial Cells Co-Cultured with Astrocytes. Methods in Molecular Biology, 814, 415-430. https://doi.org/10.1007/978-1-61779-452-0_28
|
[34]
|
Gil, E., Venturini, C., Stirling, D., et al. (2022) Pericyte Derived Chemokines Amplify Neutrophil Recruitment across the Cerebrovascular Endothelial Barrier. Methods in Molecular Biology, 13, Article 935798. https://doi.org/10.3389/fimmu.2022.935798
|
[35]
|
Jansson, D., Rustenhoven, J., Feng, S., et al. (2014) A Role for Human Brain Pericytes in Neuroinflammation. Journal of Neuroinflammation, 11, Article No. 104. https://doi.org/10.1186/1742-2094-11-104
|
[36]
|
Armulik, A., Genové, G., Mäe, M., et al. (2010) Pericytes Regulate the Blood-Brain Barrier. Nature, 468, 557-561. https://doi.org/10.1038/nature09522
|
[37]
|
Salmeri, M., Motta, C., Anfuso, C.D., et al. (2013) VEGF Receptor-1 Involvement in Pericyte Loss Induced by Escherichia coli in an in Vitro Model of Blood Brain Barrier. Cellular Microbiology, 15, 1367-1384. https://doi.org/10.1111/cmi.12121
|
[38]
|
Caporarello, N., Olivieri, M., Cristaldi, M., et al. (2018) Blood-Brain Barrier in a Haemophilus influenzae Type A in Vitro Infection: Role of Adenosine Receptors A2A and A2B. Molecular Neurobiology, 55, 5321-5336. https://doi.org/10.1007/s12035-017-0769-y
|
[39]
|
Kim, J., Alejandro, B., Hetman, M., et al. (2020) Zika Virus Infects Pericytes in the Choroid Plexus and Enters the Central Nervous System through the Blood-Cerebrospinal Fluid Barrier. PLOS Pathogens, 16, e1008204. https://doi.org/10.1371/journal.ppat.1008204
|
[40]
|
Kurlansky, P.A., Sadeghi, A.M., Michler, R.E., et al. (1986) Role of the Carrier Solution in Cyclosporine Pharmacokinetics in the Baboon. The Journal of Heart and Lung Transplantation, 5, 312-316.
|
[41]
|
Zhang, X.W., An, M.X., Huang, Z.K., et al. (2023) Lpp of Escherichia coli K1 Inhibits Host ROS Production to Counteract Neutrophil-Mediated Elimination. Redox Biology, 59, Article ID: 102588. https://doi.org/10.1016/j.redox.2022.102588
|
[42]
|
Zhang, K., Shi, M.J., Niu, Z., et al. (2019) Activation of Brain Endothelium by Escherichia coli K1 Virulence Factor CglD Promotes Polymorphonuclear Leukocyte Transendothelial Migration. Medical Microbiology and Immunology, 208, 59-68. https://doi.org/10.1007/s00430-018-0560-3
|
[43]
|
Yang, J., Ma, W., Wu, Y., et al. (2021) O-Acetylation of Capsular Polysialic Acid Enables Escherichia coli K1 Escaping from Siglec-Mediated Innate Immunity and Lysosomal Degradation of E. coli-Containing Vacuoles in Macrophage-Like Cells. Microbiology Spectrum, 9, e0039921. https://doi.org/10.1128/spectrum.00399-21
|
[44]
|
Chambers, C.A., Lacey, C.A., Brown, D.C., et al. (2021) Nitric Oxide Inhibits Interleukin-1-Mediated Protection against Escherichia coli K1-Induced Sepsis and Meningitis in a Neonatal Murine Model. Immunology & Cell Biology, 99, 596-610. https://doi.org/10.1111/imcb.12445
|
[45]
|
Chang, A.C., Krishnan, S. and Prasadarao, N.V. (2016) The Effects of Cytotoxic Necrotizing Factor 1 Expression in the Uptake of Escherichia coli K1 by Macrophages and the Onset of Meningitis in Newborn Mice. Virulence, 7, 806-818. https://doi.org/10.1080/21505594.2016.1192730
|
[46]
|
Shanmuganathan, M.V., Krishnan, S., Fu, X. and Prasadarao, N.V. (2014) Escherichia coli K1 Induces Pterin Production for Enhanced Expression of Fcγ Receptor I to Invade RAW 264.7 Macrophages. Microbes and Infection, 16, 134-141. https://doi.org/10.1016/j.micinf.2013.10.013
|
[47]
|
Krishnan, S., Liu, F., Abrol, R., et al. (2014) The Interaction of N-Glycans in Fcγ Receptor I α-Chain with Escherichia coli K1 Outer Membrane Protein A for Entry into Macrophages: Experimental and Computational Analysis. Journal of Biological Chemistry, 289, 30937-30949. https://doi.org/10.1074/jbc.M114.599407
|
[48]
|
Lu, J., Ding, J., Chu, B., et al. (2023) Inactive Trojan Bacteria as Safe Drug Delivery Vehicles Crossing the Blood-Brain Barrier. Nano Letters, 23, 4326-4333. https://doi.org/10.1021/acs.nanolett.3c00563
|
[49]
|
Chen, H., Zhou, M., Zeng, Y., et al. (2022) Biomimetic Lipopolysaccharide-Free Bacterial Outer Membrane-Functionalized Nanoparticles for Brain-Targeted Drug Delivery. Advanced Science, 9, e2105854. https://doi.org/10.1002/advs.202105854
|
[50]
|
Zhang, J., Sun, H., Gao, C., et al. (2021) Development of a Chitosan-Modified PLGA Nanoparticle Vaccine for Protection against Escherichia coli K1 Caused Meningitis in Mice. Journal of Nanobiotechnology, 19, Article No. 69. https://doi.org/10.1186/s12951-021-00812-9
|
[51]
|
Masri, A., Khan, N.A., Zoqratt, M.Z.H.M., et al. (2021) Transcriptome Analysis of Escherichia coli K1 after Therapy with Hesperidin Conjugated with Silver Nanoparticles. BMC Microbiology, 21, Article No. 51. https://doi.org/10.1186/s12866-021-02097-2
|
[52]
|
Gu, H., Liao, Y., Zhang, J., et al. (2018) Rational Design and Evaluation of an Artificial Escherichia coli K1 Protein Vaccine Candidate Based on the Structure of OmpA. Frontiers in Cellular and Infection Microbiology, 8, Article 172. https://doi.org/10.3389/fcimb.2018.00172
|
[53]
|
Pons, S., Frapy, E., Sereme, Y., et al. (2023) A High-Throughput Sequencing Approach Identifies Immunotherapeutic Targets for Bacterial Meningitis in Neonates. eBioMedicine, 88, Article ID: 104439. https://doi.org/10.1016/j.ebiom.2023.104439
|
[54]
|
Xu, X., Zhang, L., Cai, Y., et al. (2020) Inhibitor Discovery for the E. coli Meningitis Virulence Factor IbeA from Homology Modeling and Virtual Screening. Journal of Computer-Aided Molecular Design, 34, 11-25. https://doi.org/10.1007/s10822-019-00250-8
|
[55]
|
Zeng, Q., He, X.L., Xiao, H.S., et al. (2017) Lactobacillus rhamnosus GG Conditioned Medium Prevents E. coli Meningitis by Inhibiting Nuclear Factor-κB Pathway. Journal of Southern Medical University, 37, 24-29.
|
[56]
|
Yu, J.Y., Zhang, B., Peng, L., et al. (2015) Repositioning of Memantine as a Potential Novel Therapeutic Agent against Meningitic E. coli-Induced Pathogenicities through Disease-Associated α7 Cholinergic Pathway and RNA Sequencing-Based Transcriptome Analysis of Host Inflammatory Responses. PLOS ONE, 10, e0121911. https://doi.org/10.1371/journal.pone.0121911
|
[57]
|
Krishnan, S., Shanmuganathan, M.V., Behenna, D., et al. (2014) Angiotensin II Receptor Type 1—A Novel Target for Preventing Neonatal Meningitis in Mice by Escherichia coli K1. The Journal of Infectious Diseases, 209, 409-419. https://doi.org/10.1093/infdis/jit499
|